Here’s a concise update on the latest news about glyphosate-based herbicides.
A landmark 25-year-old safety study of glyphosate has been retracted amid questions about authorship and reliance on unpublished Monsanto data; this has intensified calls for the EPA and other regulators to reassess glyphosate’s cancer risk profile. These developments come as debates over glyphosate regulation continue in several jurisdictions, with some groups urging stricter review or suspension while authorities maintain existing risk assessments.[1][2]
Health agencies in some countries have faced renewed scrutiny or calls for precautionary action in light of the retraction and new studies suggesting potential cancer links or other health concerns at doses previously deemed safe; responses vary by country but commonly emphasize continuing regulatory evaluation rather than immediate bans. Public and legal pressure around glyphosate exposure remains high in agriculture, with ongoing litigation and activist campaigns highlighting possible health and environmental risks.[2][4][9][10]
International research in 2025–2026 further explored carcinogenicity concerns, including studies suggesting DNA and microbiome impacts at low exposure and calls for broader international reviews; these findings contribute to a broader scientific and political discourse on glyphosate safety and regulation. Overall usage remains widespread globally, underscoring the tension between agricultural productivity and potential health risks in policy discussions.[4][5][10][2]
Illustration: A quick timeline shows (1) longstanding EPA/global assessments affirming relative safety, (2) a high-profile retraction, (3) renewed regulatory reviews and litigation-driven disclosures, and (4) ongoing calls for precautionary action from health and environmental groups.[10][1][2]
If you’d like, I can pull the most current regulatory bodies’ statements from your country (USA, Canada, EU) and summarize their positions side-by-side, with direct quotes and publication dates.
Problems with a 25-year-old landmark paper on the safety of Roundup's active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.
www.nytimes.comThe journal Regulatory Toxicology and Pharmacology retracted the paper last week, citing documents made public through litigation in the U.S. The retraction notice cited documents made public through litigation in the U.S. that suggest employees of Monsanto, which makes Roundup, may have helped write the article without proper acknowledgment — a practice known as ghostwriting. The retraction notice said the conclusions on whether glyphosate causes cancer were "solely based on unpublished...
www.cbc.caFriends of the Earth Australia (FoEA) believes that social and environmental issues cannot be separated from each other. As a result, FoEA is a social and environmental justice organisation. We seek to work toward a sustainable and equitable future, and to operate in a way that empowers individuals and communities. This means that all members of FoEA operates on a collective basis, and utilises the consensus decision-making model to work towards the aims and objectives of the federation, and...
www.foe.org.auEffects found at doses considered safe by regulatory agencies
www.gmwatch.orgA comprehensive carcinogenicity study on the world’s most used herbicide, glyphosate, involving scientists from Europe and the U.S., has found that low doses of the controversial weed killer cause multiple types of cancer in rats.
publichealth.gmu.eduCheck out this page via the Business and Human Rights Centre
www.business-humanrights.orgNew paper is "critical step forward in filling knowledge gaps of glyphosate carcinogenicity in humans". Report: Claire Robinson
www.gmwatch.org